PMC:7283670 / 129014-129272 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T106","span":{"begin":107,"end":128},"obj":"Body_part"},{"id":"T107","span":{"begin":124,"end":128},"obj":"Body_part"},{"id":"T108","span":{"begin":130,"end":133},"obj":"Body_part"},{"id":"T109","span":{"begin":200,"end":203},"obj":"Body_part"}],"attributes":[{"id":"A106","pred":"fma_id","subj":"T106","obj":"http://purl.org/sig/ont/fma/fma0326143"},{"id":"A107","pred":"fma_id","subj":"T107","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A108","pred":"fma_id","subj":"T108","obj":"http://purl.org/sig/ont/fma/fma0326143"},{"id":"A109","pred":"fma_id","subj":"T109","obj":"http://purl.org/sig/ont/fma/fma0326143"}],"text":" other correspondents viral epidemics (Casadevall \u0026 Pirofski, 2020; Cunningham, Goh, \u0026 Koh, 2020).\n\n7.5.2 Mesenchymal stem cell (MSC) therapy\nA new therapeutic for treating immune‐mediated diseases, MSC therapy might have the capability to terminate the ina"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T204","span":{"begin":107,"end":128},"obj":"http://purl.obolibrary.org/obo/CL_0000134"},{"id":"T205","span":{"begin":130,"end":133},"obj":"http://purl.obolibrary.org/obo/CL_0000134"},{"id":"T206","span":{"begin":143,"end":144},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T207","span":{"begin":200,"end":203},"obj":"http://purl.obolibrary.org/obo/CL_0000134"}],"text":" other correspondents viral epidemics (Casadevall \u0026 Pirofski, 2020; Cunningham, Goh, \u0026 Koh, 2020).\n\n7.5.2 Mesenchymal stem cell (MSC) therapy\nA new therapeutic for treating immune‐mediated diseases, MSC therapy might have the capability to terminate the ina"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1063","span":{"begin":100,"end":142},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" other correspondents viral epidemics (Casadevall \u0026 Pirofski, 2020; Cunningham, Goh, \u0026 Koh, 2020).\n\n7.5.2 Mesenchymal stem cell (MSC) therapy\nA new therapeutic for treating immune‐mediated diseases, MSC therapy might have the capability to terminate the ina"}